419 related articles for article (PubMed ID: 26636923)
1. Steroids are a risk factor for Kaposi's sarcoma-immune reconstitution inflammatory syndrome and mortality in HIV infection.
Fernández-Sánchez M; Iglesias MC; Ablanedo-Terrazas Y; Ormsby CE; Alvarado-de la Barrera C; Reyes-Terán G
AIDS; 2016 Mar; 30(6):909-14. PubMed ID: 26636923
[TBL] [Abstract][Full Text] [Related]
2. Immune reconstitution inflammatory syndrome associated with Kaposi sarcoma: higher incidence and mortality in Africa than in the UK.
Letang E; Lewis JJ; Bower M; Mosam A; Borok M; Campbell TB; Naniche D; Newsom-Davis T; Shaik F; Fiorillo S; Miro JM; Schellenberg D; Easterbrook PJ
AIDS; 2013 Jun; 27(10):1603-13. PubMed ID: 23462220
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for Kaposi's sarcoma in HIV-positive subjects in Uganda.
Ziegler JL; Newton R; Katongole-Mbidde E; Mbulataiye S; De Cock K; Wabinga H; Mugerwa J; Katabira E; Jaffe H; Parkin DM; Reeves G; Weiss R; Beral V
AIDS; 1997 Nov; 11(13):1619-26. PubMed ID: 9365767
[TBL] [Abstract][Full Text] [Related]
4. Steroid-exacerbated HIV-associated cutaneous Kaposi's sarcoma immune reconstitution inflammatory syndrome: 'Where a good intention turns bad'.
Chabria S; Barakat L; Ogbuagu O
Int J STD AIDS; 2016 Oct; 27(11):1026-9. PubMed ID: 26769754
[TBL] [Abstract][Full Text] [Related]
5. Successful treatment of an HIV-positive patient with unmasking Kaposi's sarcoma immune reconstitution inflammatory syndrome.
Speicher DJ; Sehu MM; Johnson NW; Shaw DR
J Clin Virol; 2013 Jul; 57(3):282-5. PubMed ID: 23578530
[TBL] [Abstract][Full Text] [Related]
6. Clinical characteristics, predictors of immune reconstitution inflammatory syndrome and long-term prognosis in patients with Kaposi sarcoma.
Volkow P; Cesarman-Maus G; Garciadiego-Fossas P; Rojas-Marin E; Cornejo-Juárez P
AIDS Res Ther; 2017 May; 14(1):30. PubMed ID: 28558783
[TBL] [Abstract][Full Text] [Related]
7. Immune reconstitution inflammatory syndrome associated with Kaposi's sarcoma.
Bower M; Nelson M; Young AM; Thirlwell C; Newsom-Davis T; Mandalia S; Dhillon T; Holmes P; Gazzard BG; Stebbing J
J Clin Oncol; 2005 Aug; 23(22):5224-8. PubMed ID: 16051964
[TBL] [Abstract][Full Text] [Related]
8. Incidence of Kaposi's sarcoma and associated mortality in Fresno, California, 1998 to 2012.
Mu A; Rutledge J; Mills P; Paul S
J Int Assoc Provid AIDS Care; 2014; 13(6):526-8. PubMed ID: 24739208
[TBL] [Abstract][Full Text] [Related]
9. Recrudescent Kaposi's sarcoma after initiation of HAART: a manifestation of immune reconstitution syndrome.
Leidner RS; Aboulafia DM
AIDS Patient Care STDS; 2005 Oct; 19(10):635-44. PubMed ID: 16232048
[TBL] [Abstract][Full Text] [Related]
10. Mortality disparities among patients with HIV-associated Kaposi's sarcoma in the southern United States.
Knights SM; Lazarte SM; Kainthla R; Chiao EY; Nijhawan AE
AIDS; 2022 Apr; 36(5):721-728. PubMed ID: 34930860
[TBL] [Abstract][Full Text] [Related]
11. AIDS-associated Kaposi's sarcoma is linked to advanced disease and high mortality in a primary care HIV programme in South Africa.
Chu KM; Mahlangeni G; Swannet S; Ford NP; Boulle A; Van Cutsem G
J Int AIDS Soc; 2010 Jul; 13():23. PubMed ID: 20615222
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for Kaposi's sarcoma in patients with advanced human immunodeficiency virus disease treated with zidovudine. Zidovudine Epidemiology Study Group.
Gallant JE; Moore RD; Richman DD; Keruly J; Chaisson RE
Arch Intern Med; 1994 Mar; 154(5):566-72. PubMed ID: 8122950
[TBL] [Abstract][Full Text] [Related]
13. Facing up to the ongoing challenge of Kaposi's sarcoma.
Robey RC; Bower M
Curr Opin Infect Dis; 2015 Feb; 28(1):31-40. PubMed ID: 25490104
[TBL] [Abstract][Full Text] [Related]
14. Kaposi's sarcoma-associated herpesvirus and Kaposi's sarcoma in Africa. Uganda Kaposi's Sarcoma Study Group.
Chang Y; Ziegler J; Wabinga H; Katangole-Mbidde E; Boshoff C; Schulz T; Whitby D; Maddalena D; Jaffe HW; Weiss RA; Moore PS
Arch Intern Med; 1996 Jan; 156(2):202-4. PubMed ID: 8546554
[TBL] [Abstract][Full Text] [Related]
15. [Factors associated with survival in Kaposi's sarcoma in patients infected with the human immunodeficiency virus. Clinical Epidemiological Group for AIDS in Aquitaine].
Cazorla C; Dabis F; Dupon M; Ragnaud JM; Geniaux M; Pellegrin JL; Salmi LR
Rev Epidemiol Sante Publique; 1999 Apr; 47(2):109-17. PubMed ID: 10367298
[TBL] [Abstract][Full Text] [Related]
16. Predictors of immune reconstitution inflammatory syndrome associated with Kaposi's sarcoma: a case report.
Cattelan AM; Mattiolo A; Grassi A; Piano MA; Sasset L; Trevenzoli M; Zanovello P; Calabrò ML
Infect Agent Cancer; 2016; 11():5. PubMed ID: 26848307
[TBL] [Abstract][Full Text] [Related]
17. Kaposi's sarcoma in sub-Saharan Africa: a current perspective.
Mosam A; Aboobaker J; Shaik F
Curr Opin Infect Dis; 2010 Apr; 23(2):119-23. PubMed ID: 19996745
[TBL] [Abstract][Full Text] [Related]
18. Effect of protease inhibitor-based highly active antiretroviral therapy on survival in HIV-associated advanced Kaposi's sarcoma patients treated with chemotherapy.
Leitch H; Trudeau M; Routy JP
HIV Clin Trials; 2003; 4(2):107-14. PubMed ID: 12671778
[TBL] [Abstract][Full Text] [Related]
19. Predictors of immune reconstitution inflammatory syndrome-associated with kaposi sarcoma in mozambique: a prospective study.
Letang E; Almeida JM; Miró JM; Ayala E; White IE; Carrilho C; Bastos R; Nhampossa T; Menéndez C; Campbell TB; Alonso PL; Naniche D
J Acquir Immune Defic Syndr; 2010 Apr; 53(5):589-97. PubMed ID: 19801945
[TBL] [Abstract][Full Text] [Related]
20. Kaposi's sarcoma in patients with and without human immunodeficiency virus infection, in a tertiary referral centre in Kenya.
Mwanda OW; Fu P; Collea R; Whalen C; Remick SC
Ann Trop Med Parasitol; 2005 Jan; 99(1):81-91. PubMed ID: 15701259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
